MedPath
NMPA Approval

Dotinurad Tablets

国药准字HJ20240163

December 6, 2024

Drug Information

多替诺雷片

优乐思

片剂

1mg

化学药品

December 6, 2024

December 5, 2029

Company Information

Applicant Company

4-383, Sakuragi-Cho, Omiya-Ku, Saitama-Shi, Saitama, Japan

Manufacturing Company

fuji yakuhin co.,ltd. toyama plant

682, Fuchuu-Machi Itakura, Toyama-Shi, Toyama, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多替诺雷片 - NMPA 批准文号 | MedPath